Clinical Trial Update: Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of Arimidex (anastrozole) and Zoladex (goserelin) in premenopausal women with advanced ER and PR-positive breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Zoladex (goserelin)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED